WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from Scott Melville, president and CEO, in response to the announcement that Patrizia Cavazzoni will succeed Janet Woodcock as the permanent director of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research: “CHPA congratulates Patrizia Cavazzoni on her recent
WASHINGTON — The Consumer Healthcare Products Association (CHPA) applauds Tuesday’s passage in the U.S. Senate of S. 2740, the Over-the-Counter Drug Safety, Innovation, and Reform Act by a vote of 91-2. “Thanks to today’s decisive Senate action, our nation is one step closer to having a modern over-the-counter (O-T-C) regulatory framework that will better serve
WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement upon the introduction of the Over-the-Counter Monograph Safety, Innovation, and Reform Act, bipartisan legislation to modernize the regulatory system overseeing the vast majority of over-the-counter (O-T-C) medicines – called the O-T-C Monograph system. The legislation is sponsored by House Energy and Commerce Committee
